Who we are
At 5010AI, we’re dedicated to delivering market-leading intelligence and technology solutions for drug development — an industry we care deeply about.
Our leadership team is made up of scientists by training, with real-world experience leading programs across biotech and pharma in oncology, neuroscience, virology, and rare diseases around the globe.
Driven by our commitment to accelerating drug development, and our passion for innovative partnerships and emerging technologies, we founded 5010AI to solve complex challenges with smarter, more accessible tools.
Our initial product offerings provide deep analytics on FDA and EMA novel drug approvals. Now, we’re building a groundbreaking AI solution — one that’s specifically trained on regulatory documents, designed to support companies of all sizes. We're energized by the challenge, and proud of the progress, as we work to bring truly disruptive technology to life.
Contact us
Ready to learn more about 5010AI? We’d love to connect with you.